Agios Pharmaceuticals Inc. (AGIO)
NASDAQ · Healthcare
Agios Pharmaceuticals Inc. Net Income 2011–2025
Agios Pharmaceuticals Inc. annual/quarterly net income history and growth rate from 2011 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Agios Pharmaceuticals Inc. net income for the quarter ending March 31, 2026 was -99.1 M, a 11.00% increase year-over-year.
- Agios Pharmaceuticals Inc. net income for the twelve months ending March 31, 2026 was -403.9 M, a 159.48% decrease year-over-year.
- Agios Pharmaceuticals Inc. annual net income for 2025 was -412.8 M, a 161.27% decrease from 2024.
- Agios Pharmaceuticals Inc. annual net income for 2024 was 673.7 M, a 291.35% decrease from 2023.
- Agios Pharmaceuticals Inc. annual net income for 2023 was -352.1 M, a 51.89% increase from 2022.
- Agios Pharmaceuticals Inc. annual net income for 2022 was -231.8 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Agios Pharmaceuticals Inc. Net Income — FAQ
Agios Pharmaceuticals Inc. (AGIO) net income over the last 15 years — annual and quarterly figures with year-over-year growth and charts.
What is Agios Pharmaceuticals Inc.'s net income?
Agios Pharmaceuticals Inc. (AGIO) reported net income of -$413M for fiscal 2025.
Where can I see AGIO's net income history?
The chart and table above show Agios Pharmaceuticals Inc.'s net income by year and by quarter, including the growth rate.